|
To view this email as a web page, go here.
|
|
|
|
CME-Certified Symposium
San Francisco, May 18
|
|
|
|
|
|
|
|
|
How will assessing BRCA and other DNA repair defects help to guide your treatment decisions in prostate cancer?
Join us for this interactive symposium to find out!
 |
|
|
Friday, May 18, 2018
5:30 PM - 6:00 PM Registration and Dinner
6:00 PM - 8:00 PM Symposium
The Moscone Center South
Room: 215-216, Level 2
747 Howard Street
San Francisco, California
|
|
Johann Sebastian de Bono, MB, ChB, FRCP, MSc, PhD (Program Director)
William B. Isaacs, PhD
Todd M. Morgan, MD
|
|
|
Agenda
- Overview of DNA Repair Mechanisms and the Molecular Landscape of Advanced Prostate Cancer
– William B. Isaacs, PhD
- The Intersection of Germline and Somatic Genetic Testing in Advanced Prostate Cancer
– Todd M. Morgan, MD
- DNA Repair Defects as a Therapeutic Target in Advanced Prostate Cancer: The Role of PARP Inhibitors
– Johann Sebastian de Bono, MB, ChB, FRCP, MSc, PhD
- Challenges Moving Forward: Panel Discussion and Audience Question and Answer Session
Register and attend to receive the presentation slides before the rest of our members!
We invite you to share this event with your colleagues.
Are you an EU citizen? We don’t want to lose you—opt in to continue receiving emails.
|
|
|
|
|
|
|
|
Jointly provided by Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC.
|
|
|
Supported by an educational grant from AstraZeneca.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
